Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212448 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marta Sidoryk-Węgrzynowicz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, 02-106 Warsaw, Poland. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Protein Folding, Protein Aggregation, Pathological. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science for Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland, Ministry of Education and Science for the Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Abstract (Originalsprache)
The abnormal deposition and intercellular propagation of disease-specific protein play a central role in the pathogenesis of many neurodegenerative disorders. Recent studies share the common observation that the formation of protein oligomers and subsequent pathological filaments is an essential step for the disease. Synucleinopathies such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB) or multiple system atrophy (MSA) are neurodegenerative diseases characterized by the aggregation of the α-synucleinprotein in neurons and/or in oligodendrocytes (glial cytoplasmic inclusions), neuronal loss, and astrogliosis. A similar mechanism of protein Tau-dependent neurodegeneration is a major feature of tauopathies, represented by Alzheimer’s disease (AD), corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), and Pick’s disease (PD). The specific inhibition of the protein misfolding and their interneuronal spreading represents a promising therapeutic strategy against both disease pathology and progression. The most recent research focuses on finding potential applications targeting the pathological forms of proteins responsible for neurodegeneration. This review highlights the mechanisms relevant to protein-dependent neurodegeneration based on the most common disorders and describes current therapeutic approaches targeting protein misfolding and aggregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Institute, 02-106 Warsaw, Poland.
ORCID-Profile: Marta Sidoryk-Węgrzynowicz
Förderung
- Ministry of Education and Science for Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
- Ministry of Education and Science for the Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
Zitieren
APA
Sidoryk-Węgrzynowicz, M., Adamiak, K., & Strużyńska, L. (2024). Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212448
Vancouver
Sidoryk-Węgrzynowicz M, Adamiak K, Strużyńska L. Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212448
BibTeX
@article{SidorykWgrzynowicz2024,
author = {Sidoryk-Węgrzynowicz, Marta and Adamiak, Kamil and Strużyńska, Lidia},
title = {Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212448}
}
EUVIMED